Drug Candidate Reduced Inflammation of the Brain and Protected Against Cognitive Deterioration in Alzheimer’s Mouse Model
Summary: 3,6′-dithiopomalidomide (DP), an anti-inflammatory drug candidate, protected mouse models of Alzheimer’s disease against cognitive decline by reducing neuroinflammation.
Source: NIH
An anti-inflammatory drug candidate, known as 3,6′-dithiopomalidomide (DP), designed by researchers at the National Institute on Aging (NIA), protected lab mice against cognitive decline by reducing brain inflammation.
Source:
